🫁
Lung Cancer
Our lung cancer program focuses on targeted therapy for driver mutations common in South Asian never-smokers and advanced immunotherapy approaches.
Learn More
Research Themes
EGFR & ALK Targeted Therapies
Optimizing treatment sequencing for EGFR-mutant and ALK-rearranged non-small cell lung cancer using next-generation TKIs.
Liquid Biopsy Development
Circulating tumour DNA assays for early detection, treatment response monitoring, and resistance mechanism identification.
Immunotherapy Biomarkers
Identifying predictive biomarkers for PD-L1 checkpoint inhibitor response in Indian lung cancer populations.
Lung Cancer in Never-Smokers
Investigating environmental and genetic risk factors driving the rising incidence of lung cancer among non-smoking Indian women.
Clinical Trials
NCT06234506
RecruitingOsimertinib + Savolitinib in EGFR-Mutant NSCLC with MET Amplification
PI: Dr. Arvind Krishnamurthy
NCT06234507
ActivectDNA-Guided Adaptive Immunotherapy in Stage III NSCLC
PI: Dr. Jegan Thomas
Advance Lung Cancer Research
Your support powers genomic profiling and liquid biopsy research that helps doctors detect lung cancer earlier and choose the most effective treatment for each patient.
Donate Now